Primary |
Atrial Fibrillation |
30.1% |
Drug Use For Unknown Indication |
23.0% |
Product Used For Unknown Indication |
8.4% |
Arrhythmia |
4.9% |
Ventricular Tachycardia |
4.4% |
Anaesthesia |
3.5% |
Essential Hypertension |
3.5% |
Hypertension |
2.7% |
Rheumatoid Arthritis |
2.7% |
Prophylaxis |
2.2% |
Supraventricular Tachycardia |
2.2% |
Diuretic Therapy |
1.8% |
Heart Rate Irregular |
1.8% |
Anticoagulant Therapy |
1.3% |
Cardiac Disorder |
1.3% |
Cardiac Failure |
1.3% |
Cerebral Artery Occlusion |
1.3% |
Diabetes Mellitus |
1.3% |
Tachyarrhythmia |
1.3% |
Acute Coronary Syndrome |
0.9% |
|
Ventricular Tachycardia |
11.7% |
Suicide Attempt |
7.8% |
Torsade De Pointes |
6.5% |
Ventricular Extrasystoles |
6.5% |
Drug Ineffective |
5.2% |
Interstitial Lung Disease |
5.2% |
Malaise |
5.2% |
Renal Failure |
5.2% |
Atrial Fibrillation |
3.9% |
Electromechanical Dissociation |
3.9% |
Medication Error |
3.9% |
Palpitations |
3.9% |
Phlebitis |
3.9% |
Presyncope |
3.9% |
Renal Failure Acute |
3.9% |
Shock |
3.9% |
Syncope |
3.9% |
Thrombosis |
3.9% |
Troponin Increased |
3.9% |
Ventricular Fibrillation |
3.9% |
|
Secondary |
Product Used For Unknown Indication |
31.9% |
Atrial Fibrillation |
13.7% |
Drug Use For Unknown Indication |
12.2% |
Hypertension |
9.0% |
Tachycardia |
7.0% |
Ventricular Tachycardia |
4.5% |
Cardiac Disorder |
2.7% |
Arrhythmia |
2.5% |
Anaesthesia |
2.0% |
Blood Cholesterol Increased |
2.0% |
Mitral Valve Prolapse |
2.0% |
Cardiac Failure |
1.7% |
Depression |
1.5% |
Prophylaxis |
1.5% |
Ill-defined Disorder |
1.2% |
Rheumatoid Arthritis |
1.2% |
Parkinson's Disease |
1.0% |
Anxiety |
0.7% |
Coronary Artery Disease |
0.7% |
Diabetes Mellitus |
0.7% |
|
Overdose |
10.4% |
Renal Failure Acute |
9.0% |
Malaise |
7.5% |
Renal Impairment |
7.5% |
Deafness |
6.0% |
Drug Interaction |
6.0% |
Torsade De Pointes |
6.0% |
Ventricular Tachycardia |
6.0% |
Weight Increased |
6.0% |
Completed Suicide |
4.5% |
Vomiting |
4.5% |
Cardiac Failure |
3.0% |
Fracture Displacement |
3.0% |
Hypotension |
3.0% |
Interstitial Lung Disease |
3.0% |
Myocardial Infarction |
3.0% |
Nausea |
3.0% |
Neonatal Disorder |
3.0% |
Neurological Decompensation |
3.0% |
Premature Labour |
3.0% |
|
Concomitant |
Drug Use For Unknown Indication |
31.1% |
Product Used For Unknown Indication |
10.8% |
Atrial Fibrillation |
10.5% |
Hypertension |
9.3% |
Rheumatoid Arthritis |
4.6% |
Osteoporosis |
3.6% |
Prophylaxis |
3.4% |
Cardiac Disorder |
2.9% |
Diabetes Mellitus |
2.6% |
Pain |
2.5% |
Type 2 Diabetes Mellitus |
2.4% |
Arrhythmia |
2.2% |
Hypercholesterolaemia |
2.2% |
Hypothyroidism |
2.2% |
Blood Cholesterol Increased |
2.1% |
Chronic Obstructive Pulmonary Disease |
1.7% |
Depression |
1.7% |
Non-small Cell Lung Cancer |
1.5% |
Insomnia |
1.4% |
Anticoagulant Therapy |
1.3% |
|
Vomiting |
14.9% |
Cerebrovascular Accident |
5.9% |
International Normalised Ratio Increased |
5.9% |
Renal Failure Acute |
5.4% |
Weight Decreased |
5.4% |
Atrial Fibrillation |
5.0% |
Syncope |
5.0% |
Visual Impairment |
5.0% |
Pyrexia |
4.5% |
Rectal Haemorrhage |
4.5% |
Vision Blurred |
4.5% |
Loss Of Consciousness |
4.1% |
Pancytopenia |
4.1% |
Weight Increased |
4.1% |
Myocardial Infarction |
3.6% |
Nausea |
3.6% |
Oedema Peripheral |
3.6% |
Palpitations |
3.6% |
Pruritus |
3.6% |
Urinary Tract Infection |
3.6% |
|
Interacting |
Product Used For Unknown Indication |
37.5% |
Atrial Fibrillation |
27.7% |
Drug Use For Unknown Indication |
25.0% |
Hypertension |
3.6% |
Supraventricular Tachycardia |
1.8% |
Blood Cholesterol Increased |
0.9% |
Glaucoma |
0.9% |
Heart Rate Irregular |
0.9% |
Hyperthyroidism |
0.9% |
Menopause |
0.9% |
|
Renal Failure |
23.5% |
Xanthopsia |
23.5% |
Electrocardiogram Qt Prolonged |
11.8% |
Ventricular Tachycardia |
11.8% |
Drug Interaction |
5.9% |
Orthostatic Hypotension |
5.9% |
Syncope |
5.9% |
Traumatic Brain Injury |
5.9% |
Vomiting |
5.9% |
|